You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
Harvard Business School
Baxter
Colorcon

Last Updated: December 1, 2020

DrugPatentWatch Database Preview

Litigation Details for Vanda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Vanda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2018)

Docket   Start Trial Date Filed 2018-05-07
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand None Referred To
Parties APOTEX CORP.; APOTEX INC.; VANDA PHARMACEUTICALS INC.
Patents 10,071,977; 10,149,829; 9,060,995; 9,539,234; 9,549,913; 9,730,910; 9,855,241; RE46,209; RE46,284; RE46,604
Attorneys Aaron S. Lukas; Barry P. Golob; Daniel J. Klein; Derek James Fahnestock; Eric A. Stone; Eric J. Choi; Gregory F. Fischer; Jennifer R. Deneault; Joseph J. Bellew; Josephine Young; Karen Jacobs; Keri L. Schaubert; Kira A. Davis; Nicholas Groombridge; Thomas Joseph Francella , Jr.; William B. Coblentz
Firms Morris, Nichols, Arsht & Tunnell; White & Williams
Link to Docket External link to docket
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. Apotex Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .
Biologic Drugs cited in Vanda Pharmaceuticals Inc. v. Apotex Inc.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Vanda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-05-07 1 Complaint of Vanda’s U.S. Patent Nos. RE46,604 (“the RE604 patent”); 9,060,995 (“the ’995 patent”); 9,539,234 (… V. THE PATENTS-IN-SUIT (U.S. PATENT NOS. RE46,604; 9,060,995; 9,539,234; 9,549,913;… U.S. Patent No. 9,060,995 41. Vanda is the owner… (“the ’234 patent”); 9,549,913 (“the ’913 patent”); 9,730,910 (“the ’910 patent”); and 9,855,241 (“the…“the ’241 patent”) (collectively “the Asserted Patents”), which, in relevant part, generally relate to External link to document
2019-12-03 118 Notice of Service U.S. Patent No. 10,071,977; (2) Defendants' Amended Invalidity Contentions Regarding U.S. Patent No. 10,149,829… 7 May 2018 1:18-cv-00689 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-12-19 120 Notice of Service Supplemental Infringement Contentions for U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Fahnestock… 7 May 2018 1:18-cv-00689 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-12-23 122 Notice of Service Invalidity Contentions Concerning U.S. Patent No. 10,071,977 2) Defendants Second Amended Invalidity …Invalidity Contentions Regarding U.S. Patent No. 10,149,829 3) Defendants Third Amended Invalidity Contentions … 7 May 2018 1:18-cv-00689 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
AstraZeneca
Moodys
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.